Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine-induced muscle weakness in awake healthy volunteers
ACTRN12617001505392Phase 4Completed
- Sponsor
- Australian Society of Anaesthetists
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of neostigmine and glycopyrronium (2 arms), sponsored by Australian Society of Anaesthetists. Primary endpoint: Maximum percent change in hand grip strength. Started Aug 2015; status: completed.
02
Drugs
neostigmineglycopyrronium
Beyond the preview
Go deeper on ACTRN12617001505392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001505392.